Progress In Liquid Biopsy Cancer Screening Yields Potential Competition Between China And The U.S.

Progress In Liquid Biopsy Cancer Screening Yields Potential Competition Between China And The U.S.

Two research teams recently reported results from studies involving the long-term evaluation of non-invasive DNA fragments in blood. Evaluating these DNA fragments is called liquid biopsy, and this type of biopsy could vastly improve outcomes through early detection and low false positive rates for a wide variety of cancers. One result is Chinese and the … Read more